iBio, Inc.
IBIO
$0.818
$0.0253.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -9.40% | 48.71% | -145.21% | 61.37% |
| Total Depreciation and Amortization | -- | 1.08% | -3.81% | -14.24% | 6.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -- | 16.41% | -91.89% | 783.89% | -121.77% |
| Change in Net Operating Assets | -- | 38.25% | 82.21% | -2,040.95% | 12.50% |
| Cash from Operations | -- | -4.15% | 23.47% | -32.84% | 22.35% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.14% | -- | -100.00% | -- |
| Cash from Investing | -- | -100.28% | 595.14% | -114.40% | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -2.41% | 86.60% | -742.86% | -37.38% |
| Issuance of Common Stock | -- | 350.00% | -99.97% | 232.76% | 3.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 6.17% | -101.25% | 158.55% | 25.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -27.15% | -139.58% | 237.16% | 438.23% |